MegazoneCloud, GC Biopharma 'AI-based Quality Document Writing Support' System Construction

• Document automation using Megazone AIR reduces report writing time by 80% and enhances consistency

Megazone Cloud (CEO Yom Dong-hoon), a leading AI and cloud company, has successfully built an AI-based system to streamline quality document creation for GC Biopharma (CEO Huh Eun-chul).

Through the construction of this quality document creation support system, GC Biopharma has increased the reliability and consistency of annual product evaluation reports and product trend analysis reports, reduced document creation time by more than 80%, and achieved quality innovation and operational efficiency.

The newly built system is based on Megazone Cloud's generative AI consulting service 'Megazone AIR Consulting' and generative AI operations management service 'Megazone AIR Build', and Amazon Web Services (AWS)'s fully managed AI service 'Amazon Bedrock'. It was developed by applying Anthropic's latest large language model (LLM) 'Claude 3.7' and retrieval-augmented generation (RAG) technology. RAG is a technology designed to enable LLMs to search internal databases and external information in real-time beyond simply pre-trained data and reflect them in responses.

Previously, data from SAP, quality management systems, and laboratory information management systems had to be manually collected and compiled to create documents. This resulted in significant time spent on simple repetitive tasks, and there were difficulties in ensuring consistency as document structure and format varied depending on the person in charge. This system supports draft creation to minimize work time in accordance with the European Union's GMP guidelines (Annex 22^[1]), and the final report is structured to be confirmed only after review by the relevant business personnel.

Kang Hyung-mook, Head of Digital Innovation at GC Biopharma, said, "By reducing document creation time through AI, the business team can now focus more on substantially improving quality management levels, and from the company's perspective, we have created an opportunity to lead digital innovation in the pharmaceutical industry. We plan to continue expanding AI adoption in various fields to continuously enhance competitiveness in the pharmaceutical industry."

Gong Sung-bae, Chief AI Officer (CAIO) at Megazone Cloud, said, "The successful construction of this system demonstrates that AI and cloud technology can deliver real results even in complex data and strictly regulated environments like the pharmaceutical industry. Starting with this collaboration, we will provide broader support for digital innovation across the healthcare industry."

Megazone Cloud is a leading AI and cloud-native company with 2,000 cloud and AI technology experts, serving as a digital transformation (DX) partner for over 8,000 domestic and international customers. Based on strategic partnerships with major global and domestic cloud service providers (CSPs), the company supports customer innovation and growth through 150+ ISV partners and self-developed cloud, AI, and security solutions. Under the vision of 'Transform, Tomorrow, Together', the company is creating future competitiveness for customers through technology, data, and the passion of its employees. Megazone Cloud operates local subsidiaries in 9 countries including Korea, North America, Japan, Southeast Asia, and Oceania, growing together with customers as a global partner.